Biogen (NasdaqGS:BIIB) Conference November 13, 2025 04:30 PM ET Speaker1Good afternoon and welcome once again to TD Cowen's 2025 I&I Summit. I'm Phil Nadeau, one of the biotech analysts here at Cowen, and it's my pleasure to moderate a fireside chat with Biogen. We have with us today Diana Gallagher, who is the Head of Clinical Development of MS, immunology, and Alzheimer's disease at Biogen. Diana, thanks for joining us today. I thought we'd start with maybe a few broad overview questions before diving int ...